Clinical Trials on Recurrent Head and Neck Cancer

Total 53669 results

University of Chicago

Active, not recruiting

A Randomized, Double-Blind Phase II Study of Adjuvant Pembrolizumab Versus Placebo in Head and Neck Cancers at High Risk for Recurrence- the PATHWay Study

Head and Neck Cancer | Squamous Cell Carcinoma of the Head and Neck

United States
National Cancer Institute (NCI)

Terminated

FR901228 in Treating Patients With Refractory Stomach Cancer or Gastroesophageal Junction Cancer

Recurrent Gastric Cancer | Adenocarcinoma of the Stomach | Adenocarcinoma of the Esophagus | Recurrent Esophageal Cancer

United States
AstraZeneca

Completed

IRESSA in Combination With Cisplatin & Radiotherapy in Patients With Advanced Head & Neck Carcinoma

Cancer of Head and Neck

Spain
Chang Bing Show Chwan Memorial Hospital

Unknown

The Effect of Ganoderma on Patients With Head-and-neck Cancer

Head-and-neck Cancer

Taiwan
Sidney Kimmel Cancer Center at Thomas Jefferson...
Merck Sharp & Dohme LLC

Completed

Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung Cancer

Head and Neck Squamous Cell Carcinoma | Metastatic Renal Cell Cancer | Recurrent Head and Neck Carcinoma | Recurrent Lung Carcinoma | Recurrent Renal Cell Carcinoma | Recurrent Skin Carcinoma | Stage III Renal Cell Cancer | Stage IV Lung Cancer | Stage IV Skin Melanoma

United States
Hospices Civils de Lyon

Completed

DNA Repair Enzyme Signature in Head and Neck Cancer (CHEMRAD) (CHEMRAD)

Head Cancer | Neck Cancer

France
Radiation Therapy Oncology Group
GlaxoSmithKline; Novartis

Completed

TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer. (TRYHARD)

Non-HPV Locally Advanced Head and Neck Cancer

United States, Canada
Tel-Aviv Sourasky Medical Center

Unknown

Effect of Radiation Therapy Among Head and Neck Cancer Patients on the Inner Ear Function

Head and Neck Cancer Patients Treated With Radiotherapy
University Health Network, Toronto

Withdrawn

Feeding Tube in Cancer Patients

Enteral Feeding for Head and Neck Cancer Patients
Thomas Jefferson University

Completed

Effects of Human Papillomavirus Diagnosis on Relationships of Patients With Head and Neck Cancer

Head and Neck Carcinoma

United States
AZ Sint-Jan AV

Recruiting

Value of Geriatric Screening to Predict Postoperative Morbidity for Head and Neck Cancer (GEROP)

Head and Neck

Belgium
University Hospital, Ghent
Fund for Scientific Research, Flanders, Belgium

Completed

A Study of the Effect on Oro-dental Complications of Intensity Modulated Radiotherapy (IMRT) Versus Conventional Radiotherapy in Patients With Cancer of the Head or Neck

Cancer: Head or Neck

Belgium
IntraGel Therapeutics

Not yet recruiting

A Single Arm, Prospective, Open Label, Multi Center, Phase Ib Study to Evaluate the Safety, Tolerability and Initial Efficacy of a Single Intra-tumoral Injection of IntraGel's Polymer-based Cisplatin-loaded Gel (TumoCure) in Subjects With Progressive or Radio-resistant Primary Head and Neck Tumor

Head and Neck Cancer

Israel
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Bioelectrical Impedance Analysis in Estimating Body Composition in Patients With Stage I-IV Head and Neck Cancer Undergoing Radiation Therapy

Head and Neck Carcinoma

United States
Gustave Roussy, Cancer Campus, Grand Paris

Active, not recruiting

Evaluation of the Contribution of Transoral Robotic-assisted Surgery Using Da Vinci Xi for Head and Neck Tumors (TORS)

Head and Neck Cancer

France
Sidney Kimmel Cancer Center at Thomas Jefferson...

Completed

Remote Activity Monitored by Fitbit Charge 3 in Investigating Daily Step and Sleep Data in Participants With Head and Neck Cancer Undergoing Radiation Therapy

Head and Neck Carcinoma

United States
Jonsson Comprehensive Cancer Center

Withdrawn

Near-Infrared Image Guided Surgical Resection With Indocyanine Green in Treating Patients With Head and Neck Cancer

Head and Neck Carcinoma

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Withdrawn

Nestle Impact Advanced Recovery in Improving Surgery Recovery in Patients With Head and Neck Cancer

Head and Neck Carcinoma

United States
Bristol-Myers Squibb
Ono Pharma USA Inc

Completed

Effectiveness and Safety of Nivolumab in Participants That Have Head and Neck Cancer That Has Come Back or Has Spread

Cancer of Head and Neck | Cancer of the Head | Cancer of the Neck

Japan
University of Arkansas

Recruiting

Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence

Squamous Cell Carcinoma of Head and Neck

United States
TyrNovo Ltd.

Active, not recruiting

A Study to Evaluate NT219 Alone and in Combination With ERBITUX® (Cetuximab) in Adults With Advanced Solid Tumors and Head and Neck Cancer

Head and Neck Cancer | Squamous Cell Carcinoma of Head and Neck | Metastatic Solid Tumor | Colorectal Adenocarcinoma | Solid Tumor, Adult | Recurrent Solid Tumor

United States, Israel
University of Alabama at Birmingham

Completed

Pilot Trial of Microsphere Oxycodone (Xtampza ER) for Pain Management in Patients Receiving Radiotherapy for Locally Advanced Head and Neck Cancer (RAD 1702)

Locally Advanced Head and Neck Cancer

United States
Memorial Sloan Kettering Cancer Center

Completed

Reconstructive Surgery For Head And Neck Cancer Patients

Advanced Stage Head and Neck Cancer

United States
Mayo Clinic
Nova Southeastern University

Completed

Validity and Reliability of Outcome Measures in Patients With Cancer of the Head and Neck

Head and Neck Cancer

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Single Agent Armodafinil for Patient-Reported Fatigue Following Radiation Therapy for Head and Neck Cancer

Fatigue | Head And Neck Cancer

United States
University of Pittsburgh
Eli Lilly and Company; Genentech, Inc.

Completed

Radiation, Cetuximab and Pemetrexed With or Without Bevacizumab in Locally Advanced Head and Neck Cancer

Cancer

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Smoking Cessation Treatment for Head & Neck Cancer Patients

Smoking Cessation | Head and Neck Cancer

United States
University of Pittsburgh
Bristol-Myers Squibb

Completed

Docetaxel, Cetuximab and Cisplatin Followed by Radiation, Cetuximab and Cisplatin in Head and Neck Cancer

Cancer

United States
Stanford University
National Cancer Institute (NCI)

Completed

Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Squamous Neck Carcinoma of the Head and Neck Cancer (SCCHN)

United States
Bristol-Myers Squibb

Active, not recruiting

A Study of Nivolumab in Patients With Head and Neck Cancer. (ProNiHN)

Squamous Cell Carcinoma of the Head and Neck; Head and Neck Cancer; Head and Neck Carcinoma; Cancer of the Head and Neck

France
Hoag Memorial Hospital Presbyterian

Recruiting

PET MRI as a Staging Tool for Head and Neck Cancer

Head Cancer | Neck Cancer

United States
Assistance Publique Hopitaux De Marseille

Completed

Pharmacokinetics and Pharmacogenetics-based Adaptive Dosing of 5-fu (5-Fluorouracile) in Head & Neck Cancer Patient Undergoing Docetaxel, Cisplatin, 5-Fluorouracile (=TPF) Therapy (5-FU)

Patients With Head and Neck Cancer (ORL)

France
University Hospital Heidelberg

Completed

Multiparametric Photoacoustic Imaging in the Course of Radiation Therapy of Malignant Head and Neck Tumors

Head and Neck Cancer

Germany
H. Lee Moffitt Cancer Center and Research Institute

Completed

IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid Tumors

Renal Cell Carcinoma | Non-Small Cell Lung Cancer | NSCLC | Solid Tumor | Metastatic Cancer | Squamous Cell Carcinoma of the Head and Neck | Urothelial Carcinoma | Squamous Cell Carcinoma | Recurrent Cancer

United States
OHSU Knight Cancer Institute

Recruiting

An Exercise Prehabilitation Intervention for Improving Mobility and Recovery Outcomes in Patients Undergoing Head and Neck Cancer Surgery

Head and Neck Carcinoma

United States
University College, London

Withdrawn

Photoacoustic Imaging of Head and Neck Tumours

Head and Neck Cancer
Institut Claudius Regaud
University Hospital, Caen; Centre Francois Baclesse; Onco-Occitanie (Toulouse)

Completed

FALCOn (Facteur AnthropoLogique Cancer Orl) (FALCOn)

Head and Neck Cancer | Head and Neck Carcinoma

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Effect of the Rehabilitation Effort at Home in Patients With Head and Neck Tumor Treated With Curative Intent (NUTRIMOUV)

Head and Neck Cancer

France
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Not yet recruiting

Tirelizumab in Combination With Carboplatin and Polymeric Micellar Paclitaxel for Neoadjuvant Therapy in cN+ HNSCC

Head and Neck Cancer | Head and Neck Squamous Cell Carcinoma | HNSCC | Head Cancer Neck
Danish Cancer Society
The Ministry of Science, Technology and Innovation, Denmark; Sygekassernes...

Completed

Use of Computer-based Patient-reported Data to Assess Long Term and Late Effects of Head and Neck Cancer at the Point-of-care

Late Effects | Head and Neck Cancer Patients

Denmark
Lund University Hospital

Completed

A Study of Cisplatin Plus Radiotherapy Compared to Cetuximab Plus Radiotherapy in Locally Advanced Head and Neck Cancer. (ARTSCANIII)

Locally Advanced Head and Neck Cancer

Sweden
University Hospital Heidelberg

Recruiting

Carbon Ion Re-Radiotherapy in Patients With Recurrent or Progressive Locally Advanced Head-and-Neck Cancer (CARE)

Locally Advanced Head-and-Neck Cancer

Germany
Groupe Oncologie Radiotherapie Tete et Cou

Completed

Reirradiation and Erbitux in the HNSCC

Head and Neck Cancer Squamous Cell

France
University of Oklahoma

Recruiting

"QUAD SHOT" Radiotherapy With Pembrolizumab in Patients With Recurrent Head & Neck Cancer (QUADSHOT)

Head and Neck Cancer

United States
Rakuten Medical, Inc.

Recruiting

ASP-1929 Photoimmunotherapy (PIT) Study in Recurrent Head/Neck Cancer for Patients Who Have Failed at Least Two Lines of Therapy

Head and Neck Cancer

United States, Taiwan, Japan, India, Ukraine
Maastricht Radiation Oncology

Recruiting

Outcome Prediction in Head&Neck Cancer Patients After Radiotherapy (OutcomeH&N)

Head and Neck Cancer

Netherlands
Susanne Arnold
Eli Lilly and Company

Terminated

Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Neck Cancer

Head and Neck Cancer

United States
AstraZeneca

Completed

ZD1839 (IRESSA™) in Combination With Docetaxel & Cisplatin in Subjects With Metastatic Head & Neck Cancer

Head and Neck Cancer

Spain
Washington University School of Medicine
Celgene Corporation

Active, not recruiting

Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC) (APA)

Head and Neck Cancer | Squamous Cell Carcinoma of the Head and Neck | Cancer of Head and Neck | Neoplasms, Head and Neck | Cancer of the Head and Neck | Carcinoma, Squamous Cell of the Head and Neck

United States
Royal Marsden NHS Foundation Trust

Not yet recruiting

IReC-Bio and IReC Registry (IReC-Bio)

Head Cancer Neck

Clinical Trials on Recurrent Head and Neck Cancer

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations